US 12156914
Pharmaceutical compositions comprising bupropion and cysteine
granted A61KA61K31/137A61K31/198
Quick answer
US patent 12156914 (Pharmaceutical compositions comprising bupropion and cysteine) held by AXSOME THERAPEUTICS, INC. expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AXSOME THERAPEUTICS, INC.
- Grant date
- Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/137, A61K31/198, A61K31/485, A61K47/542